Hyperglycemia and reduced adiposity of streptozotocin-induced diabetic mice are not alleviated by oral benzylamine supplementation

Figure 2 Non-fasting and fasting blood glucose in normoglycemic and STZ-induced diabetic mice during Bza supplementation. A: Blood glucose measured every three days at 12:00 in diabetic (squares) and nondiabetic mice (circles) drinking water (open symbols) or Bza 0.5% (Bza-drinking, closed symbols) for 24 d; B: Overnight fasted blood glucose levels at the end of experiment for the same groups of mice. Mean ± SEM of n = 8 males in each group. Different from nondiabetic mice at: ^aP < 0.001. No significant difference was found between Bza drinking and respective controls. STZ: Streptozotocin; Bza: Benzylamine; Expt end: The end of experiment.